Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

NovaBay Pharmaceuticals (NBY) Shares Outstanding (Diluted Average) (2016 - 2025)

NovaBay Pharmaceuticals (NBY) has disclosed Shares Outstanding (Diluted Average) for 5 consecutive years, with $5.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 408.74% to $5.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.9 million, a 408.74% increase, with the full-year FY2011 number at -$200.0, changed N/A from a year prior.
  • Shares Outstanding (Diluted Average) was $5.9 million for Q3 2025 at NovaBay Pharmaceuticals, up from $5.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $5.9 million in Q3 2025 to a low of $120000.0 in Q1 2024.